(Q40697952)

22 September 2017

Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines (English)

1 reference

22 September 2017

1 reference

Robson H

1

1 reference

22 September 2017

Meyer S

2

1 reference

22 September 2017

Shalet SM

3

1 reference

22 September 2017

Anderson E

4

1 reference

22 September 2017

Roberts S

5

1 reference

22 September 2017

Eden OB

6

1 reference

22 September 2017

1 December 2002

1 reference

22 September 2017

Pediatric Blood Cancer

1 reference

22 September 2017

39

1 reference

22 September 2017

6

1 reference

22 September 2017

573-580

1 reference

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

22 September 2017

1 reference

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

21 January 2018

1 reference

What is the place of carboplatin in paediatric oncology?

21 January 2018

1 reference

Carboplatin versus cisplatin in solid tumors: an analysis of the literature

21 January 2018

1 reference

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

21 January 2018

1 reference

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group.

21 January 2018

1 reference

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

Oxaliplatin: a review of preclinical and clinical studies.

21 January 2018

1 reference

Comparison of the efficacy of 7-hydroxystaurosporine (UCN-01) and other staurosporine analogs to abrogate cisplatin-induced cell cycle arrest in human breast cancer cell lines

21 January 2018

1 reference

Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin

21 January 2018

1 reference

Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action

21 January 2018

1 reference

A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI).

21 January 2018

1 reference

Prospective randomized trial between two doses of granulocyte colony-stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent or refractory solid tumors: a children's cancer group report

21 January 2018

1 reference

Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer

21 January 2018

1 reference

Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).

21 January 2018

1 reference

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

21 January 2018

1 reference

The molecular basis of cisplatin sensitivity/resistance

21 January 2018

1 reference

Modulation of cis-diamminedichloroplatinum(II) resistance: a review

21 January 2018

1 reference

Synergistic enhancement of resistance to cisplatin in human bladder cancer cells by overexpression of mutant-type p53 and Bcl-2.

21 January 2018

1 reference

Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity

21 January 2018

1 reference

Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells

21 January 2018

1 reference

p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3.

21 January 2018

1 reference

p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis

21 January 2018

1 reference

p53 functions as a cell cycle control protein in osteosarcomas

21 January 2018

1 reference

Cisplatin-induced apoptosis and p53 gene status in a cisplatin-resistant human ovarian carcinoma cell line

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MPO.10076

1 reference

release_eb72547kufhrvha6lb2qsdfjfm

22 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eb72547kufhrvha6lb2qsdfjfm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference